Latest News
Communication from the GPhC regarding Regulatory Concerns
Communication from the GPhC regarding Regulatory Concerns Regarding the Supply and Promotion of Weight-Management Medicines – Mounjaro®, Wegovy® and Related GLP-1 Therapies
Professional Indemnity Insurance
Pharmacists need to check their Professional Indemnity Insurance to ensure that it covers them for the services they are providing, and to ensure that the level of cover is sufficient.
FDA Warning Letters
The MHRA has reviewed its current approach to contacting UK Licence Holders who may be implicated by USFDA Warning Letters